MIST Projected Dividend Yield
Milestone Pharmaceuticals Inc ( NASDAQ : MIST )Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. Co. is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Co. designed and is developing as a rapid-onset nasal spray to be administered by patients. Co. is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications. 21 YEAR PERFORMANCE RESULTS |
MIST Dividend History Detail MIST Dividend News MIST Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |